LexDanaLexDanabeta
Inventor

Christopher Rinsch

Inventor
Morges, CH

Overview

25→
Patents
1999–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 25 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C07DHeterocyclic compounds12%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for8%
A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or propionic acid bacteria used in foodstuffs or food preparation8%
A61LMethods or apparatus for sterilising materials or objects in general8%
C12NMicroorganisms or enzymes8%
Y02ATechnologies for adaptation to climate change5%
A23CDairy products, e.g. milk, butter or cheese2%
A23KFodder2%
PatentTitleYear
11,020,373Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof202110,988,453Compositions comprising an urolithin compound202110,857,126Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders202010,792,276Urolithins as immune response enhancers202010,695,320Compositions comprising urolithin compounds202010,532,992Prodrugs of urolithins and uses thereof202010,485,782Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders201910,442,784Compositions comprising an urolithin compound201910,028,932Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders20189,994,542Prodrugs of urolithins and uses thereof20189,980,980Compounds, compositions and methods for protecting brain health in neurodegenerative disorders20189,962,366Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof20189,872,850Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders20189,573,922'Process-scale synthesis of urolithins'20179,394,269'Process-scale synthesis of urolithins'20169,173,906'Methods and compositions for tissue regeneration'20158,933,217'Compounds, compositions, and methods for protecting brain health in neurodegenerative disorders'20158,679,475'Methods and compositions for tissue regeneration'20148,323,638'Methods and compositions for tissue regeneration'20128,137,965'Methods and compositions for tissue regeneration'20127,879,605'Methods and compositions for tissue regeneration'20117,700,351'Methods and compositions for tissue regeneration'20107,449,333'Methods and compositions for tissue regeneration'20087,144,729'Methods and compositions for tissue regeneration'20065,952,226'Hypoxia responsive EPO producing cells'1999

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1999–2012Based in Lausanne, CH· patent location history
2006–2008Patents assigned to DFB PHARMACEUTICALS INC (2)· patent assignee history
2010–2012Patents assigned to DFB TECHNOLOGY HOLDINGS LLC (4)· patent assignee history
2012Patents assigned to HUNZIKER THOMAS (2)· patent assignee history
2012Patents assigned to MIS BEATRICE (2)· patent assignee history
2014–2021Based in Morges, CH· patent location history
2015–2021Patents assigned to AMAZENTIS SA (16)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
AMAZENTIS SA162015–2021
DFB TECHNOLOGY HOLDINGS LLC42010–2012
DFB PHARMACEUTICALS INC22006–2008
HUNZIKER THOMAS22012
MIS BEATRICE22012
Locations
LocationPatentsSpan
Morges, CH182014–2021
Lausanne, CH71999–2012